Clinical Context
A typical patient is an adult with a diagnosis of chronic migraine who presents to an infusion center or outpatient clinic for administration of an intravenous or intravenous/infusion-related biologic therapy. The clinician orders J3032 (injection, eptinezumab-jjmr, 1 mg) for parenteral administration as a preventive migraine therapy. The patient arrives for a scheduled visit after prior authorization is obtained when required by the payer. Clinical workflow includes verification of identity and consent, allergy review, medication reconciliation, baseline vital signs, and assessment of recent migraine frequency and response to prior therapies.
During the visit a registered nurse prepares the dose per prescribing information, performs an IV placement if required (note: eptinezumab is administered intravenously), administers the medication over the required infusion time, and monitors the patient during and after infusion for infusion-related reactions. Post-infusion documentation includes lot number, dose administered, route, start and end times, patient tolerance, and any adverse events. The encounter may include evaluation and management services if an unrelated problem is addressed on the same day.